Alana Clayton,前首席财务干事,在涉及医疗装置付款的据称阴谋中,面临2 300万美元以上的欺诈指控。 Alana Clayton, former CFO, faces fraud charges over $2.3M in alleged scheme involving medical device payments.

前公司旅行管理首席执行官Alana Clayton于2026年1月在布里斯班法院出庭,因据称2016年至2019年间的不诚实收益超过230万美元而面临欺诈指控。 Alana Clayton, former CFO of Corporate Travel Management, appeared in Brisbane court in January 2026 facing fraud charges over alleged dishonest gains exceeding $2.3 million between 2016 and 2019. 她被指控通过MediVance提供的医疗设备计划为她本人、Elliott Lacaze和另一个人获得付款。 She is accused of securing payments for herself, Elliott Lacaze, and another individual through a scheme involving medical devices supplied by MediVance. 本案是卫生监察员办公室更广泛调查的一部分,调查将Clayton与神经外科医生Richard Laherty和外科医生Dihan Aponso联系起来。 Dihan Aponso被指控在2017年至2022年期间在昆士兰州医院使用外科手术设备,接受MediVance的回扣。 The case is part of a broader investigation by the Office of the Health Ombudsman linking Clayton to neurosurgeon Richard Laherty and surgeon Dihan Aponso, who are accused of accepting kickbacks from MediVance in exchange for using its surgical devices at Queensland hospitals between 2017 and 2022. Laherty,MediVance的部分所有者,据称谎称对相机设备的付款付款撒谎。 Laherty, a partial owner of MediVance, allegedly lied about payments being for camera equipment. 所有被告将于2026年2月16日接受联合听审。 All defendants are set to face joint hearings on February 16, 2026. 该公司表示,Clayton的辞职与指控无关。 The company stated Clayton’s resignation was unrelated to the allegations.